US Food and Drug Administration, United States
Anthem, Inc. (Ownership Interest includes stock, stock options, patent or other intellectual property)
Estimating Real-world Outcomes Under a Rapidly Evolving Treatment Paradigm: Dexamethasone and Inpatient Mortality Among US Hospitalized COVID-19 Patients
Friday, August 26, 20225:30 PM – 5:45 PM CEST
